Expertise in
4
conditions

Dr. Frank S. Eder

Family Medicine
United Health Services (Uhs)
33-57 Harrison St, 
Johnson City, NY 
Expertise in
4
conditions
United Health Services (Uhs)
33-57 Harrison St, 
Johnson City, NY 

Overview

Frank Eder is a primary care provider, practicing in Family Medicine in Johnson City, New York.

Dr. Eder is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hygroma Cervical, Cavernous Lymphangioma, Cystic Hygroma, Abdominal Cystic Lymphangioma, and Ureteroscopy.

He is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 8 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in NY

Hospital Affiliations

United Health Services Hospitals, Inc
Our Lady Of Lourdes Memorial Hospital, Inc

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
MVP Health
  • EPO
  • PPO
PacificSource
  • PPO
Sunshine Health
  • EPO
  • HMO
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

United Health Services (Uhs)
33-57 Harrison St, Johnson City, NY 13790
Other Locations
Empire Vision Center Inc.
1290 Upper Front St, Binghamton, NY 13901

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase IIb, Randomized, Observer-Blind Study to Describe the Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents
A Phase IIb, Randomized, Observer-Blind Study to Describe the Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Combination product
Study Phase: Phase 2
A Phase IIIB, Randomized, Observer-blind, Multicenter Study to Assess the Safety and Immunogenicity of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine to Healthy Subjects of 16-18 Years of Age
A Phase IIIB, Randomized, Observer-blind, Multicenter Study to Assess the Safety and Immunogenicity of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine to Healthy Subjects of 16-18 Years of Age
Enrollment Status: Completed
Publish Date: March 04, 2025
Intervention Type: Combination product, Biological
Study Phase: Phase 3
A Phase II, Observer-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of a Varicella Vaccine at Various Potencies Compared With Varivax, as a First Dose, Administered in Healthy Children in Their Second Year of Life
A Phase II, Observer-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of a Varicella Vaccine at Various Potencies Compared With Varivax, as a First Dose, Administered in Healthy Children in Their Second Year of Life
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Biological
Study Phase: Phase 2
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Combination product, Biological
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Enrollment Status: Completed
Publish Date: June 04, 2021
Intervention Type: Diagnostic test, Procedure
Blood Collection Sub-Study of Exact Sciences Protocol 2018-10: An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Blood Collection Sub-Study of Exact Sciences Protocol 2018-10: An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Enrollment Status: Completed
Publish Date: May 17, 2021
Intervention Type: Other
12 Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From A Major Depressive Disorder (MDD) Having Had- Within the Current Episode- An Inadequate Response to at Least One Medication Included in GeneSight Psychotropic
12 Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From A Major Depressive Disorder (MDD) Having Had- Within the Current Episode- An Inadequate Response to at Least One Medication Included in GeneSight Psychotropic
Enrollment Status: Completed
Publish Date: January 14, 2020
Intervention Type: Genetic
Study Phase: Not Applicable
View 7 Less Clinical Trials

5 Total Publications

Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12-59 months.
Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12-59 months.
Journal: Human vaccines & immunotherapeutics
Published: September 15, 2025
Similar Doctors
Expertise in
14
conditions
Dr. Omar B. Saeed
Family Medicine
Expertise in
14
conditions
Dr. Omar B. Saeed
Family Medicine

Office

501 S Washington Ave Ste 1000, 
Scranton, PA 
 (52.7 miles away)
570-343-2383
Languages Spoken:
English
See accepted insurances

Omar Saeed is a primary care provider, practicing in Family Medicine in Scranton, Pennsylvania. Dr. Saeed is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Heart Failure, Stroke, Angiodysplasia of the Colon, Heart Transplant, and Lung Transplant.

Expertise in
6
conditions
Dr. Ian Stuppel
Family Medicine
Expertise in
6
conditions
Dr. Ian Stuppel
Family Medicine

Guthrie Lourdes Hospital

169 Riverside Dr, 
Binghamton, NY 
 (1.9 miles away)
607-798-6701
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ian Stuppel is a primary care provider, practicing in Family Medicine in Binghamton, New York. Dr. Stuppel is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Empyema, Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Asthma in Children. Dr. Stuppel is currently accepting new patients.

Expertise in
7
conditions
Dr. Susan M. Jackson
Family Medicine
Expertise in
7
conditions
Dr. Susan M. Jackson
Family Medicine

Lourdes Family Health Chenango Bridge RD

17 Chenango Bridge Rd, 
Binghamton, NY 
 (5.3 miles away)
607-772-2995
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Susan Jackson is a primary care provider, practicing in Family Medicine in Binghamton, New York. Dr. Jackson is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Asthma, Opioid Use Disorder, Maturity Onset Diabetes of the Young, and Type 2 Diabetes (T2D).

Frequently Asked Questions about Dr. Frank S. Eder

How do I make an appointment with Dr. Frank S. Eder?

You can book an appointment with Dr. Frank S. Eder by calling their office at 607-763-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Frank S. Eder a top-rated expert for Hygroma Cervical?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Frank S. Eder is classified as an Advanced expert for Hygroma Cervical, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Frank S. Eder specialize in?

While Dr. Frank S. Eder is a Family Medicine, they have specific expertise in Hygroma Cervical, Cavernous Lymphangioma, and Cystic Hygroma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Frank S. Eder participate in research or clinical trials?

Yes. Dr. Frank S. Eder has published 5 articles and abstracts on conditions like Hygroma Cervical. You can view a list of Dr. Frank S. Eder's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Frank S. Eder accept my insurance?

Dr. Frank S. Eder accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 607-763-6000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Eder's expertise for a condition
ConditionClose
      View All 78 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile